Enliven Therapeutics Inc. (ELVN) — Defensive Interval Ratio
Enliven Therapeutics Inc. (ELVN) has a Defensive Interval Ratio of 19580 days as of June 2026. Defensive assets of $759.65 Million (cash $-, short-term investments $759.65 Million, receivables $-) cover 19580 days of daily cash needs of $38.80K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Enliven Therapeutics Inc. Defensive Interval Ratio (2019–2025)
This chart shows how Enliven Therapeutics Inc.'s Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 19580 days, meaning defensive assets of $759.65 Million can fund 19580 days of operations without new revenue. For the complete balance sheet picture, see ELVN asset base.
Annual Defensive Interval Ratio for Enliven Therapeutics Inc. (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Enliven Therapeutics Inc. from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Enliven Therapeutics Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 8013 days | $363.73 Million | $45.39K/day | $- | $363.73 Million | ▲ +3671 days |
| 2024 | 4342 days | $189.32 Million | $43.60K/day | $- | $189.32 Million | ▲ +2185 days |
| 2023 | 2157 days | $153.01 Million | $70.94K/day | $- | $153.01 Million | ▲ +2157 days |
| 2022 | 0 days | $0.00 | $26.62K/day | $- | $0.00 | ▼ -2663 days |
| 2021 | 2663 days | $41.97 Million | $15.76K/day | $- | $41.97 Million | ▲ +295 days |
| 2020 | 2368 days | $40.52 Million | $17.12K/day | $- | $40.52 Million | ▲ +284 days |
| 2019 | 2084 days | $23.97 Million | $11.50K/day | $- | $23.97 Million | — |